NCT07713030 Comparative Effects of High-Intensity Interval Training and Continuous Endurance Training Among Prediabetic Patients
| NCT ID | NCT07713030 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | PreDiabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-05-01 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prediabetics is a condition where blood sugar levels are normal but not yet high enough to be diagnosed as type 2 diabetes. This phase offers a crucial point for timely intervention to delay or prevent type 2 diabetes. The objective of the study will be to find the effects of high intensity interval and continuous endurance training on glycemic control, BMI, Vo2 Max, pulmonary function and physical activity among prediabetic patients. Study design will be randomized control trial. Total 80 participants will be enrolled in study. The data will be collected from faculty of Riphah International University, Lahore. The study will be completed within 8 months after approval of synopsis. A simple random sampling will be used to assign the groups; group A and group B. Group A will be assigned high intensity interval training and group B will be assigned to continuous training.
Eligibility Criteria
Inclusion Criteria: * Sedentary lifestyle (Individuals reporting minimal structured physical activity e.g., \<30 minutes of exercise per week) . * Stable Medical Condition (No history of significant cardiovascular events, uncontrolled hypertension, or other major comorbidities). * Stable Body Weight (Stable body weight with changes less than 3 kg in the past 6 months). Exclusion Criteria: * uncontrolled hypertension * history of heart disease * myocardial infarction * stroke * Use of Specific Medications (Current use of insulin or other medications affecting glucose metabolism or exercise response) * Severe Obesity (Individuals with a BMI ≥ 40 kg/m) * High fasting blood glucose (Fasting blood glucose of \>100mg.dl-1) * Previous history of respiratory problems * Smoking
Contact & Investigator
Arjumand Bano, MS
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07713030 clinical trial?
This trial is open to participants of all sexes, aged 35 Years or older, up to 54 Years, studying PreDiabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07713030 currently recruiting?
Yes, NCT07713030 is actively recruiting participants. Contact the research team at iqbal.tariq@riphah.edu.pk for enrollment information.
Where is the NCT07713030 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07713030 clinical trial?
NCT07713030 is sponsored by Riphah International University. The principal investigator is Arjumand Bano, MS at Riphah International University. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.